BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4310150)

  • 41. The effect of prostaglandin E1 on platelet function in vitro and in vivo.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Br J Haematol; 1970 Nov; 19(5):559-71. PubMed ID: 4098211
    [No Abstract]   [Full Text] [Related]  

  • 42. Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregation.
    Kaiya H; Ofuji M; Nozaki M; Tsurumi K
    Psychopharmacol Bull; 1990; 26(3):381-4. PubMed ID: 2177206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatty acid mobilization in obese mice.
    Enser M
    Nature; 1970 Apr; 226(5241):175-7. PubMed ID: 4314321
    [No Abstract]   [Full Text] [Related]  

  • 44. Formation of cyclic adenosine 3',5'-monophosphate from adenosine in brain slices.
    Shimizu H; Daly J
    Biochim Biophys Acta; 1970 Nov; 222(2):465-73. PubMed ID: 4321547
    [No Abstract]   [Full Text] [Related]  

  • 45. Modulation of human platelet adenylate cyclase by prostacyclin (PGX).
    Gorman RR; Bunting S; Miller OV
    Prostaglandins; 1977 Mar; 13(3):377-88. PubMed ID: 191876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of chilling on platelet cyclic adenosine 3:5-monophosphate and adenylate cyclase activity.
    Zappia GC; Steiner M; Ando Y; Baldini M
    Transfusion; 1976; 16(2):122-9. PubMed ID: 176753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects in vitro of thyrotropin, cyclic 3',5'-AMP, dibutyryl cyclic 3',5'-AMP, and prostaglandin E1 on the ultrastructure of dog thyroid slices.
    Nève P; Dumont JE
    Exp Cell Res; 1970 Dec; 63(2):285-92. PubMed ID: 4321427
    [No Abstract]   [Full Text] [Related]  

  • 48. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of dibutyryl cyclic adenosinemonophosphate and prostaglandin E1 on platelet aggregation and shape changes.
    Wang TY; Hussey CV; Garancis JC
    Am J Clin Pathol; 1977 Apr; 67(4):362-7. PubMed ID: 192067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiostimulatory effects of cyclic 3',5'-adenosine monophosphate and its acylated derivatives.
    Kukovetz WR; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(3):236-54. PubMed ID: 4316610
    [No Abstract]   [Full Text] [Related]  

  • 51. Further studies of stimulation of anterior pituitary cyclic adenosine 3',5'-monophosphate formation by hypothalamic extract and prostaglandins.
    Zor U; Kaneko T; Schneider HP; McCann SM; Field JB
    J Biol Chem; 1970 Jun; 245(11):2883-8. PubMed ID: 4316367
    [No Abstract]   [Full Text] [Related]  

  • 52. Glycogenolytic effect of dibutyryl cyclic adenosine 3',5'-monophosphate in perfused rat liver.
    Levine RA; Lewis SE
    Biochem Pharmacol; 1969 Jan; 18(1):15-20. PubMed ID: 4305477
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of platelet aggregation and the platelet release reaction by alpha, omega diadenosine polyphosphates.
    Harrison MJ; Brossmer R
    FEBS Lett; 1975 Jun; 54(1):57-60. PubMed ID: 1132495
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of prostaglandins, epinephrine and NaF on human leukocyte, platelet and liver adenyl cyclase.
    Scott RE
    Blood; 1970 Apr; 35(4):514-6. PubMed ID: 4315323
    [No Abstract]   [Full Text] [Related]  

  • 55. Cyclic 3',5'-adenosine monophosphate level and adenylate cyclase activity in human blood platelets during storage in ACD solution.
    Lammerant-Guillemare E; Corcelle-Cerf F; Lammerant J
    Blut; 1977 Apr; 34(4):329-32. PubMed ID: 192396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostaglandin E1 inhibitis platelet aggregation by a pathway independent of adenosine 3',5'-monophosphate.
    Sinha AK; Colman RW
    Science; 1978 Apr; 200(4338):202-3. PubMed ID: 204997
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prostaglandin receptor site: evidence for an essential role in the action of luteinizing hormone.
    Kuehl FA; Humes JL; Tarnoff J; Cirillo VJ; Ham EA
    Science; 1970 Aug; 169(3948):883-6. PubMed ID: 4317401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.
    Lagarde M; Dechavanne M; Thouverez JP; Verry M
    Thromb Res; 1975 Apr; 6(4):345-55. PubMed ID: 166458
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of cyclic adenosine 3',5'-monophosphate in the induction of hepatic enzymes. I. Kinetics of the induction of rat liver serine dehydratase by cyclic adenosine 3',5'-monophosphate.
    Jost JP; Hsie A; Hughes SD; Ryan L
    J Biol Chem; 1970 Jan; 245(2):351-7. PubMed ID: 4312672
    [No Abstract]   [Full Text] [Related]  

  • 60. Interactions of glucagon and insulin on the metabolism of perfused livers from fasted rats.
    Menahan LA; Wieland O
    Eur J Biochem; 1969 May; 9(1):55-62. PubMed ID: 4306664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.